Search research articles
Contact Us
Filters
Showing results (141-150 of 155) with videos related to
Page
of 16
Sort By:
British Journal of Cancer
|
September 30, 2023
Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: an analysis of the IGCCCG Update database
Jakob Lauritsen, Nicolas Sauvé, Alexey Tryakin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 20, 2020
Event-Free Survival, a Prostate-Specific Antigen-Based Composite End Point, Is Not a Surrogate for Overall Survival in Men With Localized Prostate Cancer Treated With Radiation
Wanling Xie, Meredith M Regan, Marc Buyse, et al.
European Urology Open Science
|
January 13, 2025
An Overview of Patient-reported Outcomes for Men with Prostate Cancer: Results from the PIONEER Consortium
Sebastiaan Remmers, Katharina Beyer, Tariq A Lalmahomed, et al.
The Lancet. Oncology
|
December 16, 2014
Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial
Cora N Sternberg, Iwona Skoneczna, J Martijn Kerst, et al.
European Urology
|
November 14, 2019
Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized Trials
Amar U Kishan, Fang-I Chu, Christopher R King, et al.
The Lancet. Oncology
|
September 8, 2018
Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review
Madeline Pe, Lien Dorme, Corneel Coens, et al.
BMJ Open
|
April 5, 2022
Diagnostic and prognostic factors in patients with prostate cancer: a systematic review
Katharina Beyer, Lisa Moris, Michael Lardas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 6, 2021
Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium
Silke Gillessen, Nicolas Sauvé, Laurence Collette, et al.
The Lancet. Oncology
|
February 3, 2020
International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium
Corneel Coens, Madeline Pe, Amylou C Dueck, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 2, 2024
Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update Consortium
Emanuel Bührer, David D'Haese, Gedske Daugaard, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 155) with videos related to
Sort By:
Page
of 16
British Journal of Cancer
|
September 30, 2023
Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: an analysis of the IGCCCG Update database
Jakob Lauritsen, Nicolas Sauvé, Alexey Tryakin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 20, 2020
Event-Free Survival, a Prostate-Specific Antigen-Based Composite End Point, Is Not a Surrogate for Overall Survival in Men With Localized Prostate Cancer Treated With Radiation
Wanling Xie, Meredith M Regan, Marc Buyse, et al.
European Urology Open Science
|
January 13, 2025
An Overview of Patient-reported Outcomes for Men with Prostate Cancer: Results from the PIONEER Consortium
Sebastiaan Remmers, Katharina Beyer, Tariq A Lalmahomed, et al.
The Lancet. Oncology
|
December 16, 2014
Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial
Cora N Sternberg, Iwona Skoneczna, J Martijn Kerst, et al.
European Urology
|
November 14, 2019
Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized Trials
Amar U Kishan, Fang-I Chu, Christopher R King, et al.
The Lancet. Oncology
|
September 8, 2018
Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review
Madeline Pe, Lien Dorme, Corneel Coens, et al.
BMJ Open
|
April 5, 2022
Diagnostic and prognostic factors in patients with prostate cancer: a systematic review
Katharina Beyer, Lisa Moris, Michael Lardas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 6, 2021
Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium
Silke Gillessen, Nicolas Sauvé, Laurence Collette, et al.
The Lancet. Oncology
|
February 3, 2020
International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium
Corneel Coens, Madeline Pe, Amylou C Dueck, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 2, 2024
Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update Consortium
Emanuel Bührer, David D'Haese, Gedske Daugaard, et al.
Page
of 16